Brian B. Yoor is President & CFO +1 at ABBOTT LABORATORIES (ABT). They have made 4 open-market trades across 1 company since 2016, most recently 2026-05-27.
CIK 0001643528
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABT | SELL | 2020-01-28 | 2020-01-30 | $89.73 | $91.5M | +0.0% | -8.4% | +3.5% |
| ABT | SELL | 2019-08-08 | 2019-08-09 | $85.77 | $7.5M | -1.4% | -2.2% | -3.2% |
| ABT | SELL | 2019-03-01 | 2019-03-04 | $78.00 | $175K | +0.5% | +1.2% | -3.6% |
| ABT | SELL | 2017-03-01 | 2017-03-02 | $45.39 | $157K | -1.4% | -2.1% | +0.5% |
| ABT | SELL · 10b5-1 | 2016-06-01 | 2016-06-03 | $39.49 | $22K | -4.6% | +0.5% | +7.8% |
| ABT | SELL · 10b5-1 | 2016-02-29 | 2016-03-02 | $39.13 | $34K | +5.0% | +9.4% | +2.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.